Control of viremia and maintenance of intestinal CD4+ memory T cells in SHIV162P3 infected macaques after pathogenic SIVMAC251 challenge

Virology

Volumn 387, Issue 2, 2009, Pages 273-284

  Pahar, Bapi ^a   Lackner, Andrew A ^a   Piatak Jr , Michael ^b   Lifson, Jeffrey D ^b   Wang, Xiaolei ^a   Das, Arpita ^a   Ling, Binhua ^a   Montefiori, David C ^c   Veazey, Ronald S ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b SAIC FREDERICK INC   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen specific T cells; ELISPOT; Mucosal immunity; Neutralizing antibody; Rhesus macaque; SHIV; SIV; Vaccine

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ENVELOPE GENE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA;

ADMINISTRATION, INTRAVAGINAL; AIDS VACCINES; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV; IMMUNITY, CELLULAR; IMMUNIZATION; IMMUNOLOGIC MEMORY; INTESTINES; LYMPHOCYTE COUNT; MACACA MULATTA; REASSORTANT VIRUSES; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA;

MACACA; MACACA MULATTA; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 64849114359     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.02.014     Document Type: Article

References (51)

1. Abel K., Compton L., Rourke T., Montefiori D., Lu D., Rothaeusler K., Fritts L., Bost K., and Miller C.J. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses. J. Virol. 77 5 (2003) 3099-3118
2. Altfeld M., Allen T.M., Yu X.G., Johnston M.N., Agrawal D., Korber B.T., Montefiori D.C., O'Connor D.H., Davis B.T., Lee P.K., Maier E.L., Harlow J., Goulder P.J., Brander C., Rosenberg E.S., and Walker B.D. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 420 6914 (2002) 434-439
3. Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., Nguyen P.L., Khoruts A., Larson M., Haase A.T., and Douek D.C. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200 6 (2004) 749-759
4. Casimiro D.R., Wang F., Schleif W.A., Liang X., Zhang Z.Q., Tobery T.W., Davies M.E., McDermott A.B., O'Connor D.H., Fridman A., Bagchi A., Tussey L.G., Bett A.J., Finnefrock A.C., Fu T.M., Tang A., Wilson K.A., Chen M., Perry H.C., Heidecker G.J., Freed D.C., Carella A., Punt K.S., Sykes K.J., Huang L., Ausensi V.I., Bachinsky M., Sadasivan-Nair U., Watkins D.I., Emini E.A., and Shiver J.W. Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag. J. Virol. 79 24 (2005) 15547-15555
5. Cline A.N., Bess J.W., Piatak Jr. M., and Lifson J.D. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J. Med. Primatol. 34 5-6 (2005) 303-312
6. Cohen J. AIDS research. Promising prevention interventions perform poorly in trials. Science 317 5837 (2007) 440
7. Connor R.I., Montefiori D.C., Binley J.M., Moore J.P., Bonhoeffer S., Gettie A., Fenamore E.A., Sheridan K.E., Ho D.D., Dailey P.J., and Marx P.A. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J. Virol. 72 9 (1998) 7501-7509
8. Daniel M.D., Kirchhoff F., Czajak S.C., Sehgal P.K., and Desrosiers R.C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258 (1992) 1938-1941
9. Egan M.A., Charini W.A., Kuroda M.J., Schmitz J.E., Racz P., Tenner-Racz K., Manson K., Wyand M., Lifton M.A., Nickerson C.E., Fu T., Shiver J.W., and Letvin N.L. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection. J. Virol. 74 16 (2000) 7485-7495
10. Ferrantelli F., Kitabwalla M., Rasmussen R.A., Cao C., Chou T.C., Katinger H., Stiegler G., Cavacini L.A., Bai Y., Cotropia J., Ugen K.E., and Ruprecht R.M. Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies-implications for acquired immunodeficiency syndrome vaccine. J. Infect. Dis. 189 1 (2004) 71-74
11. Ferrantelli F., Rasmussen R.A., Buckley K.A., Li P.L., Wang T., Montefiori D.C., Katinger H., Stiegler G., Anderson D.C., McClure H.M., and Ruprecht R.M. Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies. J. Infect. Dis. 189 12 (2004) 2167-2173
12. Gottlieb G.S., Nickle D.C., Jensen M.A., Wong K.G., Kaslow R.A., Shepherd J.C., Margolick J.B., and Mullins J.I. HIV type 1 superinfection with a dual-tropic virus and rapid progression to AIDS: a case report. Clin. Infect. Dis. 45 4 (2007) 501-509
13. Gray R.H., Li X., Wawer M.J., Gange S.J., Serwadda D., Sewankambo N.K., Moore R., Wabwire-Mangen F., Lutalo T., and Quinn T.C. Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. Aids 17 13 (2003) 1941-1951
14. Gray R.H., Wawer M.J., Brookmeyer R., Sewankambo N.K., Serwadda D., Wabwire-Mangen F., Lutalo T., Li X., vanCott T., and Quinn T.C. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357 9263 (2001) 1149-1153
15. Harouse J.M., Gettie A., Eshetu T., Tan R.C., Bohm R., Blanchard J., Baskin G., and Cheng-Mayer C. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). J. Virol. 75 4 (2001) 1990-1995
16. Harouse J.M., Gettie A., Tan R.C., Blanchard J., and Cheng-Mayer C. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 284 5415 (1999) 816-819
17. Horton H., Vogel T.U., Carter D.K., Vielhuber K., Fuller D.H., Shipley T., Fuller J.T., Kunstman K.J., Sutter G., Montefiori D.C., Erfle V., Desrosiers R.C., Wilson N., Picker L.J., Wolinsky S.M., Wang C., Allison D.B., and Watkins D.I. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239. J. Virol. 76 14 (2002) 7187-7202
18. Hsu M., Harouse J.M., Gettie A., Buckner C., Blanchard J., and Cheng-Mayer C. Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120. J. Virol. 77 2 (2003) 989-998
19. Jost S., Bernard M.C., Kaiser L., Yerly S., Hirschel B., Samri A., Autran B., Goh L.E., and Perrin L. A patient with HIV-1 superinfection. N. Engl. J. Med. 347 10 (2002) 731-736
20. Kawada M., Tsukamoto T., Yamamoto H., Takeda A., Igarashi H., Watkins D.I., and Matano T. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine. J. Virol. 81 10 (2007) 5202-5211
21. Koff W.C., Johnson P.R., Watkins D.I., Burton D.R., Lifson J.D., Hasenkrug K.J., McDermott A.B., Schultz A., Zamb T.J., Boyle R., and Desrosiers R.C. HIV vaccine design: insights from live attenuated SIV vaccines. Nat. Immunol. 7 1 (2006) 19-23
22. Koup R.A., Safrit J.T., Cao Y., Andrews C.A., McLeod G., Borkowsky W., Farthing C., and Ho D.D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68 7 (1994) 4650-4655
23. Kumar A., Mukherjee S., Shen J., Buch S., Li Z., Adany I., Liu Z., Zhuge W., Piatak Jr. M., Lifson J., McClure H., and Narayan O. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus. Virology 301 2 (2002) 189-205
24. Larke N., Murphy A., Wirblich C., Teoh D., Estcourt M.J., McMichael A.J., Roy P., and Hanke T. Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen. J. Virol. 79 23 (2005) 14822-14833
25. Letvin N.L., Mascola J.R., Sun Y., Gorgone D.A., Buzby A.P., Xu L., Yang Z.Y., Chakrabarti B., Rao S.S., Schmitz J.E., Montefiori D.C., Barker B.R., Bookstein F.L., and Nabel G.J. Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 312 5779 (2006) 1530-1533
26. Ling B., Veazey R.S., Hart M., Lackner A.A., Kuroda M., Pahar B., and Marx P.A. Early restoration of mucosal CD4 memory CCR5 T cells in the gut of SIV-infected rhesus predicts long term non-progression. Aids 21 18 (2007) 2377-2385
27. Ling B., Veazey R.S., Luckay A., Penedo C., Xu K., Lifson J.D., and Marx P.A. SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. Aids 16 11 (2002) 1489-1496
28. Marthas M.L., Miller C.J., Sutjipto S., Higgins J., Torten J., Lohman B.L., Unger R.E., Ramos R.A., Kiyono H., McGhee J.R., et al. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV. J. Med. Primatol. 21 2-3 (1992) 99-107
29. Mascola J.R., Sambor A., Beaudry K., Santra S., Welcher B., Louder M.K., Vancott T.C., Huang Y., Chakrabarti B.K., Kong W.P., Yang Z.Y., Xu L., Montefiori D.C., Nabel G.J., and Letvin N.L. Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins. J. Virol. 79 2 (2005) 771-779
30. Mattapallil J.J., Douek D.C., Buckler-White A., Montefiori D., Letvin N.L., Nabel G.J., and Roederer M. Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge. J. Exp. Med. 203 6 (2006) 1533-1541
31. Mattapallil J.J., Douek D.C., Hill B., Nishimura Y., Martin M., and Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434 7037 (2005) 1093-1097
32. Montefiori D.C. Evaluating neutralizing antibodies against HIV, SIV and SHIV in luciferase reporter gene assays. In: Coligan J.E., Kruisbeek A.M., Margulies D.H., Shevach E.M., Strober W., and Coico R. (Eds). Current Protocols in Immunology (2004), John Wiley & Sons, New York, NY pp. 12.11.1-12.11.15.
33. Montefiori D.C., Baba T.W., Li A., Bilska M., and Ruprecht R.M. Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239delta3 in adult and infant rhesus monkeys. J. Immunol. 157 12 (1996) 5528-5535
34. Mori K., Yasutomi Y., Ohgimoto S., Nakasone T., Takamura S., Shioda T., and Nagai Y. Quintuple deglycosylation mutant of simian immunodeficiency virus SIVmac239 in rhesus macaques: robust primary replication, tightly contained chronic infection, and elicitation of potent immunity against the parental wild-type strain. J. Virol. 75 9 (2001) 4023-4028
35. Pahar B., Lackner A.A., and Veazey R.S. Intestinal double-positive CD4+CD8+ T cells are highly activated memory cells with an increased capacity to produce cytokines. Eur. J. Immunol. 36 3 (2006) 583-592
36. Pahar B., Li J., Rourke T., Miller C.J., and McChesney M.B. Detection of antigen-specific T cell interferon gamma expression by ELISPOT and cytokine flow cytometry assays in rhesus macaques. J. Immunol. Methods 282 1-2 (2003) 103-115
37. Pahar B., Wang X., Dufour J., Lackner A.A., and Veazey R.S. Virus-specific T cell responses in macaques acutely infected with SHIV(sf162p3). Virology 363 1 (2007) 36-47
38. Reynolds M.R., Weiler A.M., Weisgrau K.L., Piaskowski S.M., Furlott J.R., Weinfurter J.T., Kaizu M., Soma T., Leon E.J., MacNair C., Leaman D.P., Zwick M.B., Gostick E., Musani S.K., Price D.A., Friedrich T.C., Rakasz E.G., Wilson N.A., McDermott A.B., Boyle R., Allison D.B., Burton D.R., Koff W.C., and Watkins D.I. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J. Exp. Med. 205 11 (2008) 2537-2550
39. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., Racz P., Tenner-Racz K., Dalesandro M., Scallon B.J., Ghrayeb J., Forman M.A., Montefiori D.C., Rieber E.P., Letvin N.L., and Reimann K.A. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283 5403 (1999) 857-860
40. Smith D.M., Wong J.K., Hightower G.K., Ignacio C.C., Koelsch K.K., Daar E.S., Richman D.D., and Little S.J. Incidence of HIV superinfection following primary infection. JAMA 292 10 (2004) 1177-1178
41. van der Kuyl A.C., Kozaczynska K., van den Burg R., Zorgdrager F., Back N., Jurriaans S., Berkhout B., Reiss P., and Cornelissen M. Triple HIV-1 infection. N. Engl. J. Med. 352 24 (2005) 2557-2559
42. Van Rompay K.K., Singh R.P., Brignolo L.L., Lawson J.R., Schmidt K.A., Pahar B., Canfield D.R., Tarara R.P., Sodora D.L., Bischofberger N., and Marthas M.L. The clinical benefits of tenofovir for simian immunodeficiency virus-infected macaques are larger than predicted by its effects on standard viral and immunologic parameters. J. Acquir. Immune Defic. Syndr. 36 4 (2004) 900-914
43. Veazey R.S., Mansfield K.G., Tham I.C., Carville A.C., Shvetz D.E., Forand A.E., and Lackner A.A. Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection. J. Virol. 74 23 (2000) 11001-11007
44. Veazey R.S., Shattock R.J., Pope M., Kirijan J.C., Jones J., Hu Q., Ketas T., Marx P.A., Klasse P.J., Burton D.R., and Moore J.P. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat. Med. 9 3 (2003) 343-346
45. Veazey R.S., Tham I.C., Mansfield K.G., DeMaria M., Forand A.E., Shvetz D.E., Chalifoux L.V., Sehgal P.K., and Lackner A.A. Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo. J. Virol. 74 1 (2000) 57-64
46. Wang X., Das A., Lackner A.A., Veazey R.S., and Pahar B. Intestinal double-positive CD4+CD8+ T cells of neonatal rhesus macaques are proliferating, activated memory cells and primary targets for SIVMAC251 infection. Blood 112 13 (2008) 4981-4990
47. Wang X., Rasmussen T., Pahar B., Poonia B., Alvarez X., Lackner A.A., and Veazey R.S. Massive infection and loss of CD4+ T cells occurs in the intestinal tract of neonatal rhesus macaques in acute SIV infection. Blood 109 3 (2007) 1174-1181
48. Watkins D.I. Basic HIV vaccine development. Top HIV Med. 16 1 (2008) 7-8
49. Watkins D.I., Burton D.R., Kallas E.G., Moore J.P., and Koff W.C. Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans. Nat. Med. 14 6 (2008) 617-621
50. Wilson N.A., Reed J., Napoe G.S., Piaskowski S., Szymanski A., Furlott J., Gonzalez E.J., Yant L.J., Maness N.J., May G.E., Soma T., Reynolds M.R., Rakasz E., Rudersdorf R., McDermott A.B., O'Connor D.H., Friedrich T.C., Allison D.B., Patki A., Picker L.J., Burton D.R., Lin J., Huang L., Patel D., Heindecker G., Fan J., Citron M., Horton M., Wang F., Liang X., Shiver J.W., Casimiro D.R., and Watkins D.I. Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J. Virol. 80 12 (2006) 5875-5885
51. Wyand M.S., Manson K.H., Garcia-Moll M., Montefiori D., and Desrosiers R.C. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70 6 (1996) 3724-3733